OMEROS CORPORATION
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- $238.1M
- Website
- http://www.omeros.com/
A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With or Without Lens Replacement
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-05-07
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 78
- Registration Number
- NCT02132312
Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2014-03-21
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT02093689
- Locations
- 🇩🇪
Omeros Investigational Site, Bochum, Germany
Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease
- First Posted Date
- 2014-02-28
- Last Posted Date
- 2018-10-22
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 22
- Registration Number
- NCT02074410
Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects
- First Posted Date
- 2013-09-27
- Last Posted Date
- 2018-10-22
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01952132
Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification
- First Posted Date
- 2012-04-18
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 416
- Registration Number
- NCT01579565
Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification
- First Posted Date
- 2011-10-18
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 405
- Registration Number
- NCT01454063
Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy
- First Posted Date
- 2011-08-01
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 344
- Registration Number
- NCT01406561
- Locations
- 🇺🇸
Orthopedic Surgery Center, Seattle, Washington, United States
Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CELR)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2014-08-28
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 223
- Registration Number
- NCT01193127
Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-03-06
- Last Posted Date
- 2012-10-12
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 18
- Registration Number
- NCT00857090
- Locations
- 🇺🇸
Urology Associates, Nasville, Tennessee, United States
🇺🇸University of California Irvine Medical Center, Orange, California, United States
🇺🇸Urology Center of Colorado, Denver, Colorado, United States
Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.
- First Posted Date
- 2008-07-24
- Last Posted Date
- 2014-07-18
- Lead Sponsor
- Omeros Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT00721695
- Locations
- 🇺🇸
Shasta Eye Medical Group, Redding, California, United States
🇺🇸Davis Duehr Dean, Madison, Wisconsin, United States
🇺🇸Silverstein Eye Centers, Kansas City, Missouri, United States
© Copyright 2024. All Rights Reserved by MedPath